MapLight Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing treatments for central nervous system disorders. Its discovery platform identifies neural circuits causally linked to disease and targets them for therapeutic modulation, aiming to improve efficacy, safety, tolerability, and ease of use. The company was founded by leaders in psychiatry and neuroscience research to address the lack of circuit-specific pharmacotherapies. Its product candidate, ML-007C-MA, is a fixed-dose combination of an M1/M4 muscarinic agonist and a peripherally acting anticholinergic, being developed for schizophrenia and Alzheimer's disease psychosis, designed to activate central receptors while mitigating peripheral side effects.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market purchase | 7 | 8,553,531 | $98.86M |
| Open-market sale | 45 | 324,917 | $11.46M |
| Grant or award | 26 | 479,607 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
75 Form 4 filings on record, the earliest from Oct 28, 2025, newest first. Filing history page 3 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jonathan Gillis - Officer | Tax withholding / forfeiture | Voting Common Stock | 22,050 | $17.98 | $396K | |
| Kristopher Hanson - Officer | Tax withholding / forfeiture | Voting Common Stock | 26,007 | $17.98 | $468K | |
| Christopher A. Kroeger - Officer | Tax withholding / forfeiture | Voting Common Stock | 204,146 | $17.98 | $3.67M | |
| Novo Holdings A/S | Other | Voting Common Stock | 2,733,681 | - | - | |
| Novo Holdings A/S | Open-market purchase | Voting Common Stock | 952,941 | $17.00 | $16.20M | |
| Novo Holdings A/S | Other | Series C Preferred Stock | 26,191,207 | $0.00 | - | |
| Novo Holdings A/S | Other | Series D Preferred Stock | 19,734,671 | $0.00 | - | |
| Catalyst4, Inc. | Other | Voting Common Stock | 14,256,288 | - | - | |
| Catalyst4, Inc. | Open-market purchase | Voting Common Stock | 5,441,176 | $17.00 | $92.50M | |
| Catalyst4, Inc. | Other | Series A Preferred Stock | 148,809 | - | - | |
| Catalyst4, Inc. | Other | Series A-1 Preferred Stock | 444,846 | - | - | |
| Catalyst4, Inc. | Other | Series B Preferred Stock | 1,263,768 | - | - | |
| Catalyst4, Inc. | Other | Series B-1 Preferred Stock | 275,148 | - | - | |
| Catalyst4, Inc. | Other | Series C Preferred Stock | 5,444,807 | - | - | |
| Catalyst4, Inc. | Other | Series D Preferred Stock | 6,678,910 | - | - | |
| Maria C. Walker | Grant or award | Employee Stock Option (right to buy) | 25,604 | $0.00 | - | |
| Maria C. Walker | Grant or award | Voting Common Stock | 6,294 | $0.00 | - | |
| Vishwas Setia - Officer | Grant or award | Voting Common Stock | 43,367 | $0.00 | - | |
| Vishwas Setia - Officer | Grant or award | Employee Stock Option (right to buy) | 176,031 | $0.00 | - | |
| Anatol Kreitzer - Officer | Grant or award | Employee Stock Option (right to buy) | 146,052 | $0.00 | - | |
| Anatol Kreitzer - Officer | Grant or award | Voting Common Stock | 35,953 | $0.00 | - | |
| Erin Pennock Foff - Officer | Grant or award | Voting Common Stock | 48,275 | $0.00 | - | |
| Erin Pennock Foff - Officer | Grant or award | Employee Stock Option (right to buy) | 196,035 | $0.00 | - | |
| Kristopher Hanson - Officer | Grant or award | Employee Stock Option (right to buy) | 110,046 | $0.00 | - | |
| Kristopher Hanson - Officer | Grant or award | Voting Common Stock | 27,098 | $0.00 | - | |
| James Woodruff Lillie - Officer | Grant or award | Employee Stock Option (right to buy) | 132,023 | $0.00 | - | |
| James Woodruff Lillie - Officer | Grant or award | Voting Common Stock | 32,539 | $0.00 | - | |
| Jonathan Gillis - Officer | Grant or award | Employee Stock Option (right to buy) | 124,022 | $0.00 | - | |
| Jonathan Gillis - Officer | Grant or award | Voting Common Stock | 30,565 | $0.00 | - | |
| Christopher A. Kroeger - Officer | Other | Series C Preferred Stock | 65,477 | $0.00 | - | |
| Christopher A. Kroeger - Officer | Grant or award | Voting Common Stock | 225,693 | $0.00 | - | |
| Christopher A. Kroeger - Officer | Other | Voting Common Stock | 3,895 | - | - | |
| Christopher A. Kroeger - Officer | Grant or award | Employee Stock Option (right to buy) | 916,164 | $0.00 | - | |
| Robert C. Malenka | Grant or award | Employee Stock Option (right to buy) | 139,610 | $0.00 | - | |
| Robert C. Malenka | Other | Series C Preferred Stock | 65,477 | $0.00 | - | |
| Robert C. Malenka | Grant or award | Voting Common Stock | 34,390 | $0.00 | - | |
| Robert C. Malenka | Other | Voting Common Stock | 3,895 | - | - | |
| Timothy John Garnett | Grant or award | Voting Common Stock | 6,294 | $0.00 | - | |
| Timothy John Garnett | Grant or award | Employee Stock Option (right to buy) | 25,604 | $0.00 | - |
This is as far as the anonymous view goes. Create a free account for all 75 MPLT filings on record.
A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| Lillie James Woodruff | Officer | 22,082 | $288K | View on EDGAR | |
| - | - | - | - | View on EDGAR | |
| - | - | - | - | View on EDGAR |
MapLight Therapeutics, Inc. (MPLT) had 22 insider filings in the last 90 days, with the most recent on 2026-08-19. The full record for MPLT runs to 75 Form 4 filings, the earliest from 2025-10-28. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
7 insider purchases of MPLT were filed in the last 90 days, totaling $98.86M.
45 insider sales of MPLT were filed in the last 90 days, totaling $11.46M.
This page tracks MPLT Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add MPLT to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.